Join the EFIB conference being organized from 6-7 October in Vienna and discuss sustainable circular bioeconomy in areas such as food, materials and bioprocesses.
A year and a half after the Green Deal publication by the European Commission in December 2019, the EFIB conference will take stock of achievements made: How can Europe reach its goal to be among the global leaders of sustainable innovation? Which strategies are pursued by corporates and SMEs to apply transformative bio-based technologies?
With the 14th edition of EFIB, EuropaBio will, together with LISAvienna as local host, invite stakeholders to join for one of the first in-person conferences in the industrial biotech and bioeconomy sector for 2021. This year also marks EuropaBio’s 25th anniversary and the event will see the launch of an “EFIB Vienna statement” on priorities and vision for industrial biotechnology.
Under the main theme “Delivering the EU Green Deal: Industrial biotechnology into business”, the EFIB 2021 program features 10+ focused plenary and parallel tracks as well as roundtable sessions, attracting about 70+ speakers across the two main conference days to shed light on business and innovation strategies, technology challenges and policy frameworks.
+++ See the recording of the EFIB 2021 kick-off webinar here +++
Focus areas include novel bio-based materials for packaging, textiles and for the building sector, sustainable financing and green architecture as well as innovative food and feed solutions in the area of cell-based and plant-based products. Why biotechnology is a key enabler particularly in the food area, is discussed by Marcus Remmers, CTO of DSM, in an interview here.
Networking with peers in the bio-based industry
EFIB is an ideal platform to meet with stakeholders across the bio-based value chain, 400+ experts are expected to join. Already confirmed speakers include representatives from DSM, The Good Food Institute, Blue Horizon, Twist Biosciences, Toulouse White Biotechnology, acib, Hochland Group, Agrana, Corbion, Cargill, Revo Foods, VAN HEES, ENOUGH, White Panter, European Circular Bioeconomy Fund, Pan Biotech, Olon, De Smet Engineers, CarboFeed, enGenes, Acticell, BRAIN AG, Lenzing, Revo Foods, Egger and Sappi, among others.
As local host, Austrian capital Vienna will particularly highlight its competences in the field of industrial biotechnology and sustainable circular bioeconomy. A pre-conference day is offering a workshop by EU-project CARBAFIN and a local tour organized by LISAVienna. Further EU-funded projects, such as SUSBIND and SUSFERT will present results from their current work during the conference.
Call for posters and Start-ups wanted
EFIB offers a reduced fee for SMEs as well as for academics. Start-ups and innovators could apply for a participation in the exhibition area. The deadline ended on 30 June, but the waiting list is still open. Please see for more information here.
EFIB Stakeholder perspectives:
"In the 1990s, Vienna embarked upon a trajectory that would see it become one of the top European centers for the life sciences. In recognition of the importance of this sector, it is now a core focus of the city’s economy under its new WIEN 2030 business and innovation strategy. This also includes particular promotion of bio-based solutions for sustainable food systems, smart urban living and sustainable architecture as well as start-up creation."
Eva Czernohorszky, Director Technology Services, Vienna Business Agency
"Developing a circular bio-based economy in Europe is key to deliver the Green Deal. By de-risking investments in the bio-based industries, BBI JU has proved to be a successful model that mobilises companies, SMEs and research organisations across Europe to create new jobs and bring sustainable innovations to the market. Circular Bio-based Europe (CBE JU), the successor of BBI JU, will capitalise on the successes of BBI JU while addressing remaining gaps, stepping up its contribution to the EU’s climate targets and leading to a truly circular and sustainable bioeconomy for the next generations."
Philipp Mengal, Executive Director, BBI JU
"In 2021, EuropaBio is celebrating its 25th anniversary with a showcase of breakthroughs in biotechnology from the last quarter century. EFIB brings a focus to industrial biotechnology advances from the anniversary, with delegates able to vote for the most impactful science or business. The conference will publish the EFIB 2021 Vienna Statement, bringing industry executives together with a vision for the next 25 years of biotechnology science and business innovation in Europe."
Claire Skentelbery, Director General, EuropaBio
+++ Explore more EFIB stakeholder perspectives here +++
If you are interested to join as a speaker, exhibitor or sponsor, please contact Nathalie di Napoli: n.dinapoli(at)biocom.de